Cohen S
Front Oncol. 2024; 14:1394584.
PMID: 38868530
PMC: 11168196.
DOI: 10.3389/fonc.2024.1394584.
Strupp C, Corvaro M, Cohen S, Corton J, Ogawa K, Richert L
Int J Mol Sci. 2023; 24(17).
PMID: 37686053
PMC: 10488128.
DOI: 10.3390/ijms241713246.
Veltman C, Pennings J, van de Water B, Luijten M
Chem Res Toxicol. 2023; 36(6):805-817.
PMID: 37156502
PMC: 10283045.
DOI: 10.1021/acs.chemrestox.2c00396.
Chen S, Dong Y, Qi X, Cao Q, Luo T, Bai Z
Acta Pharm Sin B. 2022; 12(5):2252-2267.
PMID: 35646530
PMC: 9136577.
DOI: 10.1016/j.apsb.2021.11.011.
Hwang S, Yeom H, Han B, Ham B, Lee Y, Han M
Int J Mol Sci. 2020; 21(15).
PMID: 32751172
PMC: 7432388.
DOI: 10.3390/ijms21155387.
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer.
Akkol E, Genc Y, Karpuz B, Sobarzo-Sanchez E, Capasso R
Cancers (Basel). 2020; 12(7).
PMID: 32707666
PMC: 7409047.
DOI: 10.3390/cancers12071959.
Self-Assembly Of Retinoid Nanoparticles For Melanoma Therapy.
Liao H, Zhao S, Wang H, Liu Y, Zhang Y, Sun G
Int J Nanomedicine. 2019; 14:7963-7973.
PMID: 31632011
PMC: 6778447.
DOI: 10.2147/IJN.S196974.
Mechanisms of DNA-reactive and epigenetic chemical carcinogens: applications to carcinogenicity testing and risk assessment.
Kobets T, Iatropoulos M, Williams G
Toxicol Res (Camb). 2019; 8(2):123-145.
PMID: 30997017
PMC: 6417487.
DOI: 10.1039/c8tx00250a.
Goodbye to the bioassay.
Goodman J
Toxicol Res (Camb). 2018; 7(4):558-564.
PMID: 30090606
PMC: 6062362.
DOI: 10.1039/c8tx00004b.
Critical role of toxicologic pathology in a short-term screen for carcinogenicity.
Cohen S, Arnold L
J Toxicol Pathol. 2016; 29(4):215-227.
PMID: 27821906
PMC: 5097964.
DOI: 10.1293/tox.2016-0036.
Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties.
van der Laan J, Buitenhuis W, Wagenaar L, Soffers A, van Someren E, Krul C
Front Med (Lausanne). 2016; 3:45.
PMID: 27790617
PMC: 5063850.
DOI: 10.3389/fmed.2016.00045.
Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se.
Haussmann H, Fariss M
Crit Rev Toxicol. 2016; 46(8):701-34.
PMID: 27278157
PMC: 5020336.
DOI: 10.1080/10408444.2016.1182116.
Age-dependent development of liver fibrosis in Glmp (gt/gt) mice.
Nesset C, Kong X, Damme M, Schjalm C, Roos N, Loberg E
Fibrogenesis Tissue Repair. 2016; 9:5.
PMID: 27141234
PMC: 4852418.
DOI: 10.1186/s13069-016-0042-4.
Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.
Knab L, Grippo P, Bentrem D
World J Gastroenterol. 2014; 20(31):10729-39.
PMID: 25152576
PMC: 4138453.
DOI: 10.3748/wjg.v20.i31.10729.
Arecanut as an emerging etiology of oral cancers in India.
Shah G, Chaturvedi P, Vaishampayan S
Indian J Med Paediatr Oncol. 2012; 33(2):71-9.
PMID: 22988348
PMC: 3439794.
DOI: 10.4103/0971-5851.99726.
Relationship of metabolism and cell proliferation to the mode of action of fluensulfone-induced mouse lung tumors: analysis of their human relevance using the IPCS framework.
Strupp C, Banas D, Cohen S, Gordon E, Jaeger M, Weber K
Toxicol Sci. 2012; 128(1):284-94.
PMID: 22491425
PMC: 3391030.
DOI: 10.1093/toxsci/kfs127.
High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney.
Stemmer K, Perez-Tilve D, Ananthakrishnan G, Bort A, Seeley R, Tschop M
Dis Model Mech. 2012; 5(5):627-35.
PMID: 22422828
PMC: 3424460.
DOI: 10.1242/dmm.009407.
Stimulation of hydrogen peroxide production by drinking water contaminants in HL-60 cells sensitized by retinoic acid.
Yoshida H, Inoue S, Yoshida K, Nakajima O, Mizuno S
Environ Health Prev Med. 2011; 3(2):106-12.
PMID: 21432519
PMC: 2723339.
DOI: 10.1007/BF02931793.
Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors.
Stemmer K, Ellinger-Ziegelbauer H, Ahr H, Dietrich D
Am J Pathol. 2009; 175(4):1686-98.
PMID: 19717638
PMC: 2751564.
DOI: 10.2353/ajpath.2009.081071.
Melatonin prevents the development of hyperplastic urothelium induced by repeated doses of cyclophosphamide.
Zupancic D, Vidmar G, Jezernik K
Virchows Arch. 2009; 454(6):657-66.
PMID: 19381685
DOI: 10.1007/s00428-009-0765-3.
